Media - Abzena


Abzena’s 2nd Biopharmaceutical Discovery & Development Symposium

19 February 2020

Abzena are hosting the second Biopharmaceutical Discovery & Development Symposium to showcase the latest technologies[...] Read more


20 January 2019

Abzena will be at PepTalk in January 2020, we will be presenting on ADCascade: A New Clinically Based Approach for Target[...] Read more


Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more


Spotlight on Abzena’s Developability Platform during Antibody Engineering & Therapeutics 2019

New service reduces the risk, expenditure and time required for the later stages of antibody development Cambridge, UK, 9[...] Read more

Abzena Showcases Discovery and Developability Services at PEGS Europe 2019

Bespoke approach generates high affinity antibodies and selects lead candidates with the strongest chances of success in[...] Read more


We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch